The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets

Transfusion

Volumn 39, Issue 9, 1999, Pages 925-932

  Lopez Plaza, Ileana ^a   Weissfeld, J ^a   Triulzi, D J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLOIMMUNIZATION; ARTICLE; BACTERIUM CONTAMINATION; BLOOD DONOR; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SEPSIS; THROMBOCYTE TRANSFUSION; VIRUS INFECTION; VIRUS TRANSMISSION;

ADULT; BACTERIAL INFECTIONS; BLOOD DONORS; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS; COST-BENEFIT ANALYSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C; HIV INFECTIONS; HUMANS; PLATELET TRANSFUSION; QUALITY OF LIFE; RISK ASSESSMENT; VIRUS DISEASES;

EID: 0032860322     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39090925.x     Document Type: Article

References (33)

1. Slichter SJ. Platelet transfusion therapy. Hematol Oncol Clin North Am 1990;4:291-311.
2. Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995;35:802-12.
3. Sweeney JD, Petrucci J, Yankee R. Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective. Transfus Sci 1997;18:575-83.
4. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90.
5. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to reduce alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861-9.
6. Morrow JF, Braine HG, Kickler TS, et al. Septic reactions to platelet transfusions. A persistent problem. JAMA 1991;266:555-8.
7. Yomtovian R, Lazarus HM, Goodnough LT, et al. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993;33:902-9.
8. Bock M, Glaser A, Pfosser A, et al. Storage of single-donor platelet concentrates: metabolic and functional changes. Transfusion 1993;33:311-5.
9. Moroff G, Holme S. Concepts about current conditions for the preparation and storage of platelets. Transfus Med Rev 1991;5:48-59.
10. Sloand EM, Yu M, Klein HG. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections. Transfusion 1996;36:955-9.
11. Leach MF, AuBuchon JP. Effect of storage time on clinical efficacy of single-donor platelet units. Transfusion 1993;33:661-4.
12. AuBuchon JP, Littenberg B. A cost-effectiveness analysis of the use of a mechanical barrier system to reduce the risk of mistransfusion. Transfusion 1996;36:222-6.
13. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effective analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1339-41.
14. Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332:719-24.
15. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:1253-8.
16. Department of Health and Human Services Health Care Financing Administration. Medicare Program: changes to the hospital inpatient prospective payment system and fiscal year 1997 rates. Fed Regist. Aug 30, 1996:61(170: 46166-328.
17. Bloom BS, Hillman AL, Fendrick AM, Schwartz JS. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann Intern Med 1993;118:298-306.
18. Hellinger FJ. The lifetime cost of treating a person with HIV. JAMA 1993;270:474-8.
19. Beck JR, Kassirer JP, Pauker SG. A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med 1982;73:883-8.
20. Beck JR, Pauker SG, Gottlieb JE, et al. A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med 1982;73:889-97.
21. National Center for Health Statistics. Life tables. Vital statistics of the United States, 1989, vol 2, Sect 6. DHHS publication number (PHS) 93-1104. Government Printing Office, 1992.
22. New IBMTR/ABMTR slides. International Bone Marrow Transplant Registry (IBMTR) Newsletter July 1995:3-8.
23. Ferrell B, Grant M, Schmidt G, et al. The meaning of quality of life for bone marrow transplant survivors. Part 1. The impact of bone marrow transplant on quality of life. Cancer Nurs 1992;15:153-60.
24. Ferrell B, Grant M, Schmidt G, et al. The meaning of quality of life for bone marrow transplant survivors. Part 2. Improving quality of life for bone marrow transplant survivors. Cancer Nurs 1992;15:247-53.
25. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with intemal-thoracic-artery grafts - effects on survival over a 15-year period. N Engl J Med 1996;334:216-9.
26. Kelley DL, Fegan RL, Ng AT, et al. High-yield platelet concentrates attainable by continuous quality improvement reduce platelet transfusion cost and donor exposure. Transfusion 1997;37:482-6.
27. Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
28. Dodd RY. The risk of transfusion-transmitted infection (editorial). N Engl J Med 1992;327:419-21.
29. AuBuchon JP, Birkmeyer JD, Busch MP. Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion 1997;37:45-51.
30. AuBuchon JP. Lessons learned from decision analysis. Transfusion 1996;36:755-60.
31. Kelley DL, Mangini J, Lopez-Plaza I, Triulzi DJ. Utility of ≤3 day old platelets in reducing incidence of febrile transfusion reactions (abstract). Transfusion 1997;37(Suppl):83S.
32. Birkmeyer JD, AuBuchon JP, Littenberg B, et al. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg 1994;57:161-8.
33. AuBuchon JP, Birkmeyer JD. Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply. JAMA 1994;272:1210-4.